AzTrials
AzTrials

Hair RemovalNCT01282866

Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece

A study testing LightSheer Duet in people with Hair Removal, run by Lumenis Be Ltd. at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this clinical study is to verify hair count reduction, associated comfort/discomfort and treatment time using the LightSheer Duet System with the High Speed (HS) handpieces for temporary hair removal and permanent hair reduction. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Hair Removal
What is being tested?
LightSheer Duet
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
35 participants
Where
1 siteUnited States
Study dates
Jun 2009to Nov 2011
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy adult, female, 18 years of age or older with skin type I-IV;
  • Having at least one suitable treatment area for hair removal with brown hair;
  • Able and willing to comply with the treatment/follow-up schedule and requirements;
  • Able to read, understand and provide written Informed Consent.
  • Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to market preference test enrollment and throughout the course of the study treatment.

Who cannot join

  • Showing symptoms of hormonal disorders, as per the Investigator's discretion;
  • Use of oral isotretinoin (Accutane®) within 6 months
  • Prior skin treatment with laser or other devices on the same treated areas prior to study enrollment or during the course of the study;
  • History of keloid formation or poor wound healing in a previously injured skin area;
  • Significant skin conditions affecting treated area or inflammatory skin conditions;
  • Open laceration, abrasion, active cold sores or herpes sores on area to be treated;
Show all 20Show fewer
  • History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications;
  • Having a history of bleeding disorder or taking anticoagulation medications before the washout period, per the package insert, and at the physician's discretion;
  • Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the area to be treated, personal history of melanoma;
  • Significant concurrent illness, such as diabetes, lupus, epilepsy or cardiac disorders, which might be aggravated as a result of treatment;
  • Unable or unlikely to refrain from tanning, including the use of tanning booths, tanning spray or cream, during the course of the evaluation;
  • Tattoos in the treatment areas;
  • Dysplastic nevi in the treatment areas;
  • Participation in a study of another device or drug within 3 month prior to study enrollment or during this study, and as per the Investigator's careful discretion, as long as not contradictory to any of the above criteria;
  • Mentally incompetent, prisoner or evidence of active substance or alcohol abuse;
  • Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study;
  • Allergy or history of an allergy to any topical anesthetic used;
  • Pregnant, expectation of pregnancy, postpartum (<3 months) or nursing (<6 weeks);
  • History of livedo reticularis, an autoimmune vascular disease;
  • Hypersensitivity at the treatment site to any agents, solutions, or gel used in the treatment (applies to ET handpiece only), if no alternative exists;

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Laser & Skin Surgery Medical Group Inc

    Sacramento, California, 95816

Other trials in United States

About this study

The objective of this clinical study is to verify hair count reduction, associated comfort/discomfort and treatment time using the LightSheer Duet System with the High Speed (HS) handpieces for temporary hair removal and permanent hair reduction. It is anticipated that the larger treatment size of the HS handpiece will result in faster treatment of larger areas; and that the lower energy levels will result in greater comfort.

Conditions
Hair Removal
Being tested
LightSheer Duet

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LightSheer DuetDevice

    LightSheer Duet HS handpiece

Study groups in NCT01282866
Study groupRoleWhat they receive
HS treatmentExperimentalTreatment with HS handpiece
Receives: Device: LightSheer Duet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hair Count

    The hair at the treatment area is counted at Baseline and 6 months following the last treatment.

    Hair clearance is determined by the percentage of Hair left 6 months following the last treatment compared to the hair number at baseline.

    Measured: 6 month following last treatment

Secondary outcomes (3)
  1. Treatment Time

    The treatment time was measured for each participant on each and every visit. The result is presented as mean of all treatment time from all of the visits and all of the participants.

    Measured: Each treatment

  2. Level of Comfort Associated With Treatment

    Measured: Each treatment

  3. Hair Count

    The hair at the treatment area is counted at Baseline and 15 months following the last treatment.

    Hair clearance is determined by the percentage of Hair left 15 months following the last treatment compared to the hair number at baseline.

    Measured: 15 month following last treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2011 (estimated)
  2. Study startJun 2009
  3. Primary completionNov 2011
  4. Study completionNov 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
35 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01282866
Sponsor's protocol ID
LUM- ABU-LSDuet-08-001
Status last verified
Jan 2014
First submitted
9 Jan 2011
Last updated
21 Oct 2016

Questions about this trial

What is this clinical trial studying?

A study testing LightSheer Duet in people with Hair Removal, run by Lumenis Be Ltd. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 3 Apr 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hair Count (time frame: 6 month following last treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in